Reminder: Due to the state of emergency in Texas and under the guidelines of the Texas Controlled Substances Act, providers may prescribe a controlled substance telephonically to an in-network pharmacy and follow up within seven (7) days with a written prescription.

During a review of 2015 and 2016 claims processing of DEA schedule II (CII) prescription drug claims, PerformRx noticed an increase in the number of schedule II (CII) drugs being incorrectly billed as refills at the point of sale (POS). While this may have been due to an error in entering and submitting prescription claim information to PerformRx, efforts need to continually be made to prevent these types of errors as they can signal potential fraud, waste or abuse incorrectly. Pursuant to 21 U.S.C. § 829(a), refills of medications with a DEA schedule II (CII) designation are prohibited at POS.

This week's Generic News includes information on HCP reclassification and how it affects McKesson ordering; a new Price Assurance promotion; the release of generic Exforge®; and much more!

This week's Generic News contains important McKesson ordering and stock information related to the DEA's rule moving Hydrocodone Containing Products (HCPs) from Schedule III to Schedule II.

With the upcoming reclassification of hydrocodone combination products (HCPs) into Schedule II on Oct. 6, 2014, your patients may have questions or concerns about obtaining and refilling their prescriptions.